Search results
Results from the WOW.Com Content Network
(Reuters) -Viatris unit Mylan is no longer a subject of the U.S. Department of Justice's antitrust investigation into alleged price fixing in the generic drug industry, the parent company said on ...
The generic drug maker has been deemed a “value trap,” and has experienced a sharp plunge in price. Falling by about 23% right after the news, and down around 32.5% in the past month, it may ...
The Company cited the risk of the label is missing on some prefilled pens contained inside labeled cartons of the drug. The recall doesn't cover Viatris' recently launched interchangeable Semglee ...
Drug name Withdrawn Country Remarks Amphetamine Mix (Adderall XR) 2005 Canada Withdrawn over reports of increased risk of stroke, reinstated after increased risk not found. [1] Alatrofloxacin: 2006 Worldwide Serious hepatotoxicity leading to liver transplant or death. [2] Alclofenac: 1979 UK Vasculitis [3] Alpidem (Ananxyl) 1995 Worldwide
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
The batch is being recalled due to the potential for the label to be missing on some vials. Biocon Sdn manufactured this batch. Bhd. and was distributed by Mylan Specialty L.P. in the U.S. between ...
This drug had to get approval as a new drug, as opposed to a generic. Their product was called Maxzide and was approved in 1984. [ 26 ] [ 27 ] The higher dose allowed once per day dosing, which the company and its marketing partner, Lederle, believed would help it compete against Dyazide, which had $210M in sales in 1983. [ 26 ]